Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogen (NEOG) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Neogen (NEOG) over the last 16 years, with Q4 2025 value amounting to -$9.3 million.

  • Neogen's Change in Accured Expenses fell 15158.75% to -$9.3 million in Q4 2025 from the same period last year, while for Nov 2025 it was $2.3 million, marking a year-over-year increase of 11203.7%. This contributed to the annual value of -$402000.0 for FY2025, which is 10292.34% down from last year.
  • Per Neogen's latest filing, its Change in Accured Expenses stood at -$9.3 million for Q4 2025, which was down 15158.75% from $14.2 million recorded in Q3 2025.
  • Neogen's 5-year Change in Accured Expenses high stood at $42.7 million for Q4 2023, and its period low was -$32.5 million during Q1 2023.
  • In the last 5 years, Neogen's Change in Accured Expenses had a median value of -$2.6 million in 2021 and averaged $3.0 million.
  • As far as peak fluctuations go, Neogen's Change in Accured Expenses surged by 61912.48% in 2021, and later plummeted by 48689.78% in 2022.
  • Quarter analysis of 5 years shows Neogen's Change in Accured Expenses stood at $12.8 million in 2021, then surged by 191.77% to $37.4 million in 2022, then increased by 14.12% to $42.7 million in 2023, then crashed by 57.7% to $18.0 million in 2024, then plummeted by 151.59% to -$9.3 million in 2025.
  • Its Change in Accured Expenses stands at -$9.3 million for Q4 2025, versus $14.2 million for Q3 2025 and $7.1 million for Q2 2025.